Supplements to MAD NMAC Program Rules – 2024

Rule
Effective Date
Division
Medical Assistance Division (MAD)
Summary
Policy Topic
Repeal of Hepatitis C Virus (HCV) Checklist – and Elimination of Prior Authorization for Glecaprevir/Pibrentasivir (Mavyret®) and Sofosbuvir/Velpatasvir (Epclusa ®)
Chapter Title
24-06
Short Description

Supplement Numbers 24-06

Policy Topic Repeal of Hepatitis C Virus (HCV) Checklist – and Elimination of Prior Authorization for Glecaprevir/Pibrentasivir (Mavyret®) and Sofosbuvir/Velpatasvir (Epclusa ®) Replaces Supplement 20-13

Date May 14, 2024